Nutex Health Inc. filings document the reporting obligations of a healthcare services and operations company with hospital, population health management and real estate-related activities. Recent Form 8-K reports furnish operating and financial results, including revenue, hospital division performance, earnings measures and cash flow, and disclose other corporate events tied to registration statements and auditor consents.
Proxy and annual-meeting filings cover board elections, advisory executive compensation votes, auditor ratification, common stock voting results and related governance disclosures. These documents also frame the company's capital actions, including common stock repurchase authorizations, within its public-company reporting record.
Nutex Health Inc. reports that a putative securities class action was filed on August 22, 2025 in the U.S. District Court for the Southern District of Texas, captioned Anjana Bhagavan v. Nutex Health Inc. (Case No. 4:25-cv-03999).
The complaint names the company, its Chairman and Chief Executive Officer, its Chief Financial Officer, and its President and Director as defendants and asserts claims under Sections 10(b) and 20(a) of the Exchange Act and Rule 10b-5. The allegations track a recent short seller report, and the plaintiff seeks unspecified damages.
Nutex Health disputes the allegations and intends to vigorously defend the lawsuit. The company states it cannot predict the outcome or estimate the financial impact, but acknowledges that an adverse ruling could have a material adverse effect on its financial position or results of operations.
Nutex Health Inc. filed a current report announcing that on August 14, 2025 it issued a press release with certain anticipated financial results and related information. The company furnished this press release as Exhibit 99.1, specifying that the information in Item 2.02 and the exhibit is being provided for informational purposes and is not deemed filed under the Exchange Act, nor automatically incorporated into other securities filings unless specifically referenced.
Nutex Health Inc. filed a notice that it will be late filing its Quarterly Report on Form 10-Q for the period ended June 30, 2025. The company says it needs additional time to analyze the classification of certain equity instruments and to finalize its financial statements, and that filing on time would require unreasonable effort and expense.
Nutex states it expects to file the Form 10-Q within the five-calendar-day extension period allowed under SEC rules. The company confirms that all other required periodic reports over the past 12 months have been filed. It also indicates that the upcoming Form 10-Q will reflect a significant change in results of operations compared with the same period in the prior year.
Nutex Health (NASDAQ:NUTX) filed Definitive Additional Proxy Materials (DEFA14A) on June 27, 2025, supplementing its June 2, 2025 proxy statement.
The filing simply alerts shareholders that an updated proxy supplement is available, reiterates the July 14, 2025 Annual Meeting date (10:00 a.m. CT), and explains how to request or download materials via ProxyVote.com, phone, or email.
No new proposals, financial data, executive changes, or compensation revisions were disclosed.